Post-Operative Pain Control Following Shoulder Surgery
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Johns Hopkins University
- Enrollment
- 74
- Locations
- 2
- Primary Endpoint
- Morphine milligram equivalents (MMEs) consumed
Study Overview
Brief Summary
This study will evaluate overall opioid and non-narcotic analgesic use following surgical treatment for shoulder pathology, and recommend evidence based guidelines for standardized postoperative pain management.
Detailed Description
There is currently very limited information in the literature regarding postoperative pain medication consumption following orthopedic shoulder surgery. To fill this knowledge gap, this study will evaluate overall opioid consumption in morphine milligram equivalents following surgical treatment for shoulder pathology.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- Triple (Participant, Investigator, Outcomes Assessor)
Masking Description
participants will be masked to the aspect of post-operative pain management being manipulated in this study; investigator and outcomes assessor will be masked to randomization (group assignment) of participants
Eligibility Criteria
- Ages
- 18 Years to 90 Years (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Opioid-naive adults age 18-90 years old planning to undergo surgical treatment for shoulder pathology with the PI at Johns Hopkins Shoulder Service (Columbia, Odenton clinic sites; Howard County General Hospital/Johns Hopkins Hospital operative sites) will be included.
Exclusion Criteria
- •Patients with prior history of opioid misuse, addiction, or chronic pain
- •Patients taking chronic pain medication or have taken opioid medication in the past 3 months will be excluded due to risk of developing drug tolerances that could affect the amount of pain medication consumed after surgery An exception will be made for those who have used narcotic medication for fracture-related events, and expect to undergo surgical treatment for fracture repair (ORIF or arthroplasty)
- •Patients with BMI < 18.5 or > 39.9
- •Patients with a history of adverse reaction and/or allergy to oxycodone
- •Patients lacking the ability to consent will also be excluded.
- •Patients whose primary residence is outside the United States will be excluded.
- •Patients who are unable to complete questionnaires due to medical condition, psychiatric illness, or significant language barrier will also be excluded.
Outcomes
Primary Outcomes
Morphine milligram equivalents (MMEs) consumed
Time Frame: 2 weeks postop
Total possible narcotic pain medication use in MME's
Office Contacts
Time Frame: 2 weeks postop
Number of times patient contacted the office via telephone, MyChart, or email
Opioid Prescription Refills
Time Frame: 2 weeks postop
number and quantity of opioid prescription refills
Secondary Outcomes
- American Shoulder and Elbow Surgeons (ASES) score(2-4 months postop)